NCT07710690 A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma Status RECRUITING Phase PHASE1
NCT07644312 Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG Status NOT_YET_RECRUITING Phase PHASE2
NCT07424092 Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors Status RECRUITING Phase PHASE2
NCT07416188 Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT07210632 Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Status RECRUITING Phase EARLY_PHASE1
NCT07206849 Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) Status NOT_YET_RECRUITING Phase PHASE2
NCT06712875 MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas Status RECRUITING Phase PHASE1/PHASE2
NCT06528691 Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors Status RECRUITING Phase PHASE2
NCT06519682 A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) Status RECRUITING Phase NA
NCT06504381 DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma Status RECRUITING Phase PHASE1/PHASE2
NCT06357377 A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06333899 Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Status RECRUITING Phase EARLY_PHASE1
NCT06264388 DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma Status RECRUITING Phase PHASE2
NCT06215495 A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial Status RECRUITING Phase NA
NCT06072586 A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions Status RECRUITING Phase EARLY_PHASE1
NCT06016452 A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma Status RECRUITING Phase PHASE2